Company to Host Conference Call Today, March 27, at 4:30pm ETBOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and ...

Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApolstm ExTend, an RNA polymerase engineered to significantly ...

March 13, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, reported ...

Generation Bio plans to announce the target and indication for its lead ctLNP-siRNA program in mid-2025 and submit an investigational new drug (IND) application in the second half of 2026. Fourth ...

Generation Bio plans to announce the target and indication for its lead ctLNP-siRNA program in mid-2025 and submit an investigational new drug (IND) application in the second half of 2026. Fourth ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage ... lung disease (PH-ILD), today announced its financial results for the fourth quarter and year ended December 31, 2024, and provided a business ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

March 11, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB ) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis ...

Atara is also exploring alternative financing options. Research and development expenses include $2.6 million and $13.5 million of non-cash stock-based compensation expenses for the fourth quarter and ...

BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq ... today reported financial results and operational highlights for the fourth quarter and year ended December 31, 2024.

Recent Highlights: Anticipated Upcoming Milestones: FTD-GRN FTD-C9orf72 Passage Bio is pursuing several initiatives to support clinical trial recruitment and enrollment, including a collaborative ...